1 2 3 4 5 Next
Researchers track evolution and spread of drug-resistant bacteria across hospitals and continents
Researchers have used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia. The findings shed light on how these deadly bacteria are able to spread from patient to patient in a single hospital and, on a larger scale of geography and time, between countries and entire continents. (Mon, 01 Feb 2010 01:24:04 GMT)
Strong year for biotech
In retrospect, 2009 was a year of strong performance for the Malaysian biotechnology industry. Cynics will protest that we cannot claim that. But why ever not, when tangible evidence-based results abound that testify to the same? (Mon, 01 Feb 2010 04:55:30 GMT)
A human being is a union of vertebrate and virus
http://www.newscientist.com/arti The answer to our paradox is now clear: the human genome has evolved as a holobiontic union of vertebr... (Mon, 01 Feb 2010 07:41:42 GMT)
New technology to turn patients into doctors
A US doctor is predicting members of the public will soon be able to use technologies like smart phones to monitor and even treat their own health conditions. (Mon, 01 Feb 2010 07:45:56 GMT)
Korean scientists announce completion of bovine genome called Hanwoo
Korean scientists announced the completion of the de novo assembly and analysis of the genome of the native Korean bovine, called Hanwoo. (Mon, 01 Feb 2010 10:36:25 GMT)
CLC bio Expands Bioinformatics Consulting Organization in North America
AARHUS, Denmark----CLC bio announces the expansion of our North American consulting organization. The organization, based in Washington, D.C., will function as an integrated part of CLC bio’s global consulting team. (Mon, 01 Feb 2010 12:00:00 GMT)
AB SCIEX Launches as New Company to Extend Leadership in Analytical Science
FOSTER CITY, Calif. & CONCORD, Ontario----AB SCIEX today launched as a new company dedicated to life science analytical technologies. The new company combines the two halves of the highly successful AB SCIEX mass spectrometry joint venture into an integrated organization. (Mon, 01 Feb 2010 13:22:00 GMT)
Knome Featured in New PBS Series Faces of America with Henry Louis Gates, Jr.
Knome, a leading pioneer in the personal genomics field, will be featured in the new four-part PBS series Faces of America with Henry Louis Gates, Jr. The series follows Harvard scholar Henry Louis Gates, Jr. as he uses advanced genetics tools to explore the ancestral histories of 12 renowned Americans, uncovering unique stories of immigration that illuminate the American experience. (Mon, 01 Feb 2010 13:30:00 GMT)
New Computational Tool For Cancer Treatment
Many human tumors express indoleamine 2,3-dioxygenase (IDO), an enzyme which mediates an immune-escape in several cancer types. Researchers in the Molecular Modeling group at the SIB Swiss Institute of Bioinformatics and Dr. Benoît J. Van den Eynde's group at the Ludwig Institute for Cancer Research Ltd (LICR) Brussels Branch developed an approach for creating new IDO inhibitors by computer ... (Mon, 01 Feb 2010 13:31:54 GMT)
Identification Of Brain Protein For Synapse Development
A new study from UC Davis Health System identifies for the first time a brain protein called SynDIG1 that plays a critical role in creating and sustaining synapses, the complex chemical signaling system responsible for communication between neurons. The research, published in the Jan.14 issue of the journal Neuron, fills a major gap in understanding the molecular foundations of higher cognitive ... (Mon, 01 Feb 2010 13:32:14 GMT)
Research and Markets: Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery" to their offering. (Mon, 01 Feb 2010 14:01:00 GMT)
MDRNA, Inc. to Present at the 12th Annual BIO CEO & Investor Conference
Will Also Participate in a Panel Discussion on RNAi-Based Technology (Mon, 01 Feb 2010 14:26:49 GMT)
MabCure Featured in GenomeWeb
HASSELT, Belgium----MabCure, Inc. , a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies for the early detection of cancer, has been featured in a January 14, 2010 article published on GenomeWeb, the largest online news organization focused on advanced research tools in genomics, proteomics, and bioinformatics. (Mon, 01 Feb 2010 14:30:00 GMT)
Research and Markets: Renal and Urinary Proteomics: Methods and Protocols
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Renal and Urinary Proteomics: Methods and Protocols" to their offering. (Mon, 01 Feb 2010 14:42:00 GMT)
Pathway Genomics Conversation Starter #3: After Genetic Testing, What Then?
In the past few years, the science of genetic testing has advanced exponentially, both in the amount of information genetic testing can reveal and the precision and reliability of the results. It's also more convenient and affordable than ever before-making it possible for companies like Pathway Genomics to provide consumers with valuable insight into their predisposition to certain health ... (Mon, 01 Feb 2010 15:30:30 GMT)
Rosetta Genomics Fortifies Patent Position With U.S. Allowance Of Claims Covering Human MicroRNAs MiR-21 And Hcmv-miR ...
Rosetta Genomics (NASDAQ:ROSG) today announced that the United States Patent and Trademark Office has allowed claims in two patent applications. The first, covering human microRNA miR-21, was derived from the "Tuschl III" patent series that is assigned to the Max Planck Society, Berlin, Germany and is used in Rosetta's miRview™ mets and miRview™ squamous diagnostic assays. Rosetta holds a co ... (Mon, 01 Feb 2010 15:31:41 GMT)
Health research one winner in Obama budget
Health research is one potential winner in the budget proposed by President Barack Obama Monday, with the National Institutes of Health down for an extra $1 billion for medical research. (Mon, 01 Feb 2010 15:32:04 GMT)
International Team Publishes Malaria Parasite GWAS
NEW YORK (GenomeWeb News) – An international group of researchers has published the first genome-wide association study on the malaria parasite Plasmodium falciparum , looking for genes associated with antimalarial drug resistance and more. (Mon, 01 Feb 2010 15:45:34 GMT)
Funding Update
This project aims to develop efficient simulation techniques for stochastic biochemical models, particularly the cell cycle model. "Biologists have developed complex mathematical models of cell-cycle control in budding yeast, fission yeast, and mammalian cells," the grant abstract states. (Mon, 01 Feb 2010 16:05:49 GMT)
Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities
BANGALORE, India, February 1 /PRNewswire/ -- Infinitus Clinical Research is continuing to pioneer its unique strategy. (Mon, 01 Feb 2010 16:10:11 GMT)
Spectrometers and Spectrophoto/Fluorometers - Global Market Trends
NEW YORK , Feb. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Spectrometers and Spectrophoto/Fluorometers - Global Market Trends http://www.reportlinker.com/p016 Spectroscopic instruments have been crucial in the laboratory since ... (Mon, 01 Feb 2010 16:12:00 GMT)
New Report Reviews 28 Collaborative Agreements For The Co-Development Of Drug-Diagnostics
The development of genomics-based molecular diagnostics that are linked to therapeutic products is critical to targeted drug developments of the future. (Mon, 01 Feb 2010 17:19:59 GMT)
Microarray Papers of Note Published January 2010
Journal: Analytical Biochemistry . 2010 Jan 1;396(1):30-5. Title: Quantitative label-free screening for antibodies using scattering biophotonic microarray imaging. (Mon, 01 Feb 2010 17:30:32 GMT)
Health spending a winner in Obama budget
Health research is a potential winner in the budget proposed by U.S. President Barack Obama on Monday, with the National Institutes of Health in line for an extra $1 billion for medical research. (Mon, 01 Feb 2010 17:37:13 GMT)
Study Suggests MicroRNA, Tissue Evolution Closely Linked in Bilaterian Animals
A team of researchers from Germany and the US used small RNA sequencing, miRNA expression profiling, and comparative genomics to track down the active sites of conserved bilaterian miRNAs during bilaterian animal evolution. (Mon, 01 Feb 2010 21:05:20 GMT)
NEI to Support Young Genomics Data Scientists
NEW YORK (GenomeWeb News) – The National Eye Institute wants more researchers who can use statistical genetics to study ophthalmology, and will award up to $300,000 per year for five years to start training programs to begin cultivating such talent. (Mon, 01 Feb 2010 21:05:31 GMT)
Pitt to Use WaferGen SmartChip in NIH-Supported Studies
NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that the University of Pittsburgh will use its SmartChip Real-Time PCR System in genomics, gene expression, and disease studies that are funded by the National Institutes of Health. (Mon, 01 Feb 2010 21:05:39 GMT)
High-throughput analysis of gene regulation, DNA synthesis in Cold Spring Harbor Protocols
A featured article in the February 2010 issue of Cold Spring Harbor Protocols presents a high-throughput method for identifying DNase I hypersensitive sites across the whole genome. Another article presents a method for coupling BrdU immunoprecipitation with DNA microarrays to enable genome-wide identification of BrdU-labeled chromosomal DNA. Both are freely accessible on the Web site for Cold ... (Mon, 01 Feb 2010 21:27:00 GMT)
Health spending a winner in Obama budget
Health research is a potential winner in the new U.S. budget proposed on Monday, with the National Institutes of Health in line for an extra $1 billion -- the largest increase for the agency in eight years. (Mon, 01 Feb 2010 21:46:45 GMT)
Scripps Research scientists create new way to screen libraries of 10 million or more compounds
( Scripps Research Institute ) The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through -- time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because there is enormous interest in ... (Mon, 01 Feb 2010 21:48:34 GMT)
Children's Hospital Boston Researchers ID Protein That May Explain Paclitaxel Resistance
Researchers from Children's Hospital Boston have used a proteomics approach to identify a protein that may play a key role in determining why some patients fail to respond to one of the most successful cancer treatments in history. (Mon, 01 Feb 2010 22:50:28 GMT)
Scientists create new way to screen libraries of 10 million or more compounds
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through -time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because there is enormous interest in identifying synthetic molecules that ... (Mon, 01 Feb 2010 23:57:40 GMT)
Jocelyn Rose to lead Institute for Biotechnology and Life Sciences Technologies
Jocelyn Rose, professor of plant biology, has been named the new director of the Institute for Biotechnology and Life Science Technologies, effective Jan. 1. (Tue, 02 Feb 2010 00:01:12 GMT)
Scripps Research Scientists Create New Way To Screen Libraries Of 10 Million Or More Compounds
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through—time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. (Tue, 02 Feb 2010 01:16:56 GMT)
SOLiD Gold: Dietrich Stephan on Ignite’s Partnership with Life Technologies
Bio-IT World | Dietrich Stephan, the co-founder of personal genomics company Navigenics, speaks to Bio-IT World about his ambitious new institute in Northern Virginia – the Ignite Institute for Individualized Health; the newly announced partnership with Life Technologies; and the acquisition of 100 SOLiD 4 next-generation sequencing instruments. (Tue, 02 Feb 2010 07:14:52 GMT)
Project set to map marks on genome
Consortium sets sights on the differences that make us different. (Tue, 02 Feb 2010 07:49:11 GMT)
Cardiac catheterization: A groundbreaking tool in the field of cardiology
Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions. (Tue, 02 Feb 2010 09:31:47 GMT)
Scripps Research Scientists Create Innovative New Way To Screen Libraries Of 10 Million Or More Compounds, Potentially ...
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through-time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. (Tue, 02 Feb 2010 09:37:41 GMT)
Researchers Sequence Complete Genome Of Brain Cancer Cell Line
Cancer researchers at UCLA's Jonsson Comprehensive Cancer Center have performed the complete sequencing of the much-studied brain cancer cell line, U87, a discovery that may lead to targeted treatments for glioblastoma based on the unique biological signature of an individual's disease, the development of more effective and less toxic drug therapies for this aggressive tumor, and the tools to ... (Tue, 02 Feb 2010 11:42:16 GMT)
Biotech Stock Alert for Power 3 Medical Products Inc. Issued by Beacon Equity
DALLAS -- BeaconEquity.com announces an investment report featuring biotechnology company Power 3 Medical Products Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision. (Tue, 02 Feb 2010 11:50:00 GMT)
Spectrometers And Spectrophoto/Fluorometers - Global Market Trends
Reportlinker.com announces that a new market research report is available in its catalogue: Spectrometers and Spectrophoto/Fluorometers - Global Market Trends , http://www.reportlinker.com/p016 (Tue, 02 Feb 2010 12:39:13 GMT)
Dicerna to Present New Data on Dicer Substrate siRNA Molecules at Cambridge Healthtech Institute's Second Annual RNA ...
WATERTOWN, Mass.----Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA molecules, today announced that the company will present new preclinical data at the Cambridge Healthtech Institute’s Second Annual RNA Interference: From Tools to Therapies Conference, as ... (Tue, 02 Feb 2010 13:30:00 GMT)
CombiMatrix to Spend $25M Insurance Settlement on 'All Aspects of Business'
After years of requiring cash infusions to keep its nascent diagnostics business on track, CombiMatrix last week disclosed in a filing with US Securities and Exchange Commission that it has inked a settlement agreement with National Union Fire Insurance Company, under which CombiMatrix will receive $25 million, essentially ending its financing woes. (Tue, 02 Feb 2010 13:50:08 GMT)
ACLA Briefs Blues Chapter About 'Value of Genetic Testing'
ACLA and Results for Life recently briefed officials at Carefirst Blue Cross and Blue Shield in Baltimore about "the value and importance of genetic testing," according to ACLA. (Tue, 02 Feb 2010 14:20:09 GMT)
TGen becomes center of excellence for Horizon Discovery's GENESIS and X-MAN technology
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute and Horizon Discovery today announced plans to develop human disease models for use in TGen's cancer research. (Tue, 02 Feb 2010 14:33:07 GMT)
Beckman Coulter, Genpathway Collaborate on ChIP-Seq Services
NEW YORK (GenomeWeb News) – Beckman Coulter Genomics, the genomics services subsidiary of Beckman Coulter, today said that it is teaming up with Genpathway to offer customers whole-genome chromatin immunoprecipitation sequencing (ChIP-Seq) services. (Tue, 02 Feb 2010 15:20:08 GMT)
SAIC-Frederick Awards SDI Contract to Develop Antibodies for NCI's Proteomics Initiative
Strategic Diagnostics this week announced that Science Applications International Corp.-Frederick has chosen it to develop monoclonal antibodies as part of the National Cancer Institute's initiative to improve reagents for the proteomics community. (Tue, 02 Feb 2010 15:20:18 GMT)
Beckman Coulter Genomics Partners with Genpathway to Offer Comprehensive ChIP-Seq Solutions
DANVERS, Mass., and SAN DIEGO – (Feb. 2, 2010) – Beckman Coulter Genomics Inc., and Genpathway, Inc., today announced a strategic partnership to offer customers whole-genome chromatin immunoprecipitation sequencing (ChIP-Seq) services. (Tue, 02 Feb 2010 16:09:51 GMT)
UC Riverside’s New State-of-the-art Technology to Accelerate Stem Cell Research
RIVERSIDE, Calif. (Tue, 02 Feb 2010 16:31:22 GMT)
Research advances microsystems that can detect water-borne pathogens
Researchers have engineered microsystems for the detection of water-borne pathogens using a technique called dielectrophoresis (DEP), which separates and identifies cells and microparticles suspended in a medium based on their size and electrical properties. Now they have found a way to provide the nonuniform electric field required for DEP that does not require electrodes to contact the sample ... (Tue, 02 Feb 2010 17:24:52 GMT)
Scientists create new way to screen libraries of 10 million or more compounds
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through -- time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because there is enormous interest in identifying synthetic molecules ... (Tue, 02 Feb 2010 17:25:42 GMT)
Stem cell research facility opens
RIVERSIDE, Calif. (Tue, 02 Feb 2010 18:31:09 GMT)
IP Roundup
Osmetech of Pasadena, Calif., has received US Patent No. 7,655,129, "Binding acceleration techniques for the detection of analytes." The patent claims methods for accelerating the binding of target analytes to capture ligands on surfaces. (Tue, 02 Feb 2010 18:50:08 GMT)
Zygem to Market Rubicon's DNA-Amplification Kits in Australia, New Zealand
Rubicon Genomics said last week that it has tapped Zygem to market its PicoPlex single-cell amplification kits in Australia and New Zealand. (Tue, 02 Feb 2010 19:05:10 GMT)
UC Riverside's new state-of-the-art technology to accelerate stem cell research
Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) - a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories. (Tue, 02 Feb 2010 19:27:30 GMT)
Beckman Coulter Genomics, Genpathway Partner to Provide ChIP-seq Service
Beckman Coulter Genomics and Genpathway are partnering to provide customers with whole-genome chromatin immunoprecipitation sequencing services, the companies said this week. (Tue, 02 Feb 2010 20:05:20 GMT)
Study Finds Histone Modification Levels Can Predict Gene Expression
NEW YORK (GenomeWeb News) – In a paper appearing online last night in the Proceedings of the National Academy of Sciences , researchers from Germany, Croatia, and Norway report that they have come up with a bioinformatics-based approach for predicting gene expression levels in human cells based on histone modification levels. (Tue, 02 Feb 2010 20:20:08 GMT)
France's Institut Pasteur Develops Resequencing Array for Pathogen Identification
Researchers at the Institut Pasteur's Laboratory for Urgent Response to Biological Threats in Paris have developed a new resequencing microarray for use in public health emergencies triggered by exposure to pathogens. (Tue, 02 Feb 2010 20:35:18 GMT)
IP Update: Recent Patents Related to PCR, Sample Prep, and Nucleic Acid Amplification
US Patent No. 7,655,791. DNA amplification and sequencing using DNA molecules generated by random fragmentation . Inventors: Vladimir Makarov, Irina Sleptsova, Emmanuel Kamberov, Eric Bruening. Assignee: Rubicon Genomics. (Tue, 02 Feb 2010 20:35:28 GMT)
Myriad Genetics' Q2 Revenues Rise 11 Percent; Profit up 67 Percent
NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Tuesday that its second-quarter revenues climbed 11 percent due primarily to increased sales and marketing efforts and improved physician acceptance of its products. (Tue, 02 Feb 2010 23:35:08 GMT)
Millipore's Q4 Revenues up 7 Percent with Currency Boost
NEW YORK (GenomeWeb News) – Millipore reported after the close of the market Tuesday that its fourth-quarter revenues climbed 7 percent, aided by a 5 percent benefit from foreign currency translation. (Tue, 02 Feb 2010 23:35:19 GMT)
Dr. Cohan Studies Mutations, Promiscuous Sex in Bacteria
Bacteria are weird. (Wed, 03 Feb 2010 02:12:51 GMT)
Bioinformatics – bringing IT and life sciences together
Imagine trying to work through millions of bits of information, attempting to work out why a cell had suddenly turned cancerous, or why, in a population of one billion, some individuals started smoking, while others did not? (Wed, 03 Feb 2010 03:14:14 GMT)
Genetic test for 'speed gene' in thoroughbred horses
Groundbreaking research led by a leading horse genomics scientist in Ireland has resulted in the identification of the 'speed gene' in thoroughbred horses. (Wed, 03 Feb 2010 03:27:13 GMT)
OGT Launches New ISCA-Endorsed Cytosure™ Acgh Arrays For Detecting Disease And Syndrome-Related Aberrations
Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, has introduced three new CytoSure™ ISCA aCGH arrays to meet all resolution, multiplexing and budget requirements. (Wed, 03 Feb 2010 06:26:50 GMT)
10 new kits available for fast and simple isolation of nucleic acids from blood, plasma and serum
Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 10 new kits for the fast and simple isolation of nucleic acids from blood, plasma and serum, including circulating nucleic acids. (Wed, 03 Feb 2010 06:47:17 GMT)
Angrist demystifies genomics
It’s flashy, it’s new, it’s the hottest thing on the market. (Wed, 03 Feb 2010 08:14:19 GMT)
Molecular Devices Returns to Life Sciences Marketplace
SUNNYVALE, California, February 3 /PRNewswire/ -- - New Brand Launched by Molecular Devices, Inc. SUNNYVALE, California, February 3 /PRNewswire/ -- Today, Molecular Devices, Inc.-now part of Danaher Corporation-re-launched the Molecular Devices brand into the life sciences marketplace. (Wed, 03 Feb 2010 08:41:47 GMT)
UCR purchases Nikon BioStation CT technology to assist in stem cell research
Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) - a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories. (Wed, 03 Feb 2010 09:04:08 GMT)
New resources to support Teva Pharmaceutical Industries' Tjet injector system now available
Teva Pharmaceutical Industries Ltd. announced today the availability of new resources to support the recently introduced Tjet® injector system, a needle-free device designed to deliver Teva’s TEV-TROPIN® [somatropin (rDNA origin) for injection] brand human growth hormone (hGH) to children who have growth failure due to inadequate secretion of normal endogenous growth hormone. (Wed, 03 Feb 2010 09:18:57 GMT)
TGen, Horizon Discovery partner in development of novel cancer cell-lines
The Translational Genomics Research Institute (TGen) and Horizon Discovery today announced plans to develop human disease models for use in TGen's cancer research. (Wed, 03 Feb 2010 09:32:36 GMT)
CLC bio expands bioinformatics consulting organization in North America
CLC bio announced the expansion of North American consulting organization. The organization, based in Washington, will function as an integrated part of CLC bio's global consulting team. (Wed, 03 Feb 2010 10:43:46 GMT)
New Way To Screen Libraries Of 10 Million Or More Compounds
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through - time and money make it virtually impossible to screen or search through super-large libraries of potential compounds. This is a serious problem, because there is enormous interest in identifying synthetic molecules that ... (Wed, 03 Feb 2010 11:27:13 GMT)
Set platform for harnessing synergy: Guv
Port Blair, Feb 3 : Andaman and Nicobar Islands Lt Governor Bhopinder Singh today urged all the research institutions of the islands to set up a suitable platform for harnessing synergy among different research institutions for the betterment of the islanders. (Wed, 03 Feb 2010 11:35:54 GMT)
Navigenics Raises $18 Million in Series C Financing
FOSTER CITY, Calif.----Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round. (Wed, 03 Feb 2010 12:00:00 GMT)
• Nutrition expert lectures in Kannapolis
By Emily Ford eford@salisburypost.com KANNAPOLIS â Nutrition scientists at the N.C. Research Campus are working to discover and document genetic differences in people, so doctors can create personalized diets for their patients. Called "individual ... (Wed, 03 Feb 2010 12:25:04 GMT)
Rosetta Genomics Announces Issuance of Three U.S. Patents
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics today announced that the United States Patent and Trademark Office has issued three patents to the company covering the composition of matter of human microRNAs. (Wed, 03 Feb 2010 12:30:00 GMT)
ATLAS Biolabs GmbH Joins Roche NimbleGen's Certified Service Provider Program for Targeted Enrichment
MADISON, Wis.----Roche NimbleGen has announced that ATLAS Biolabs GmbH, a Berlin, Germany-based company, has officially become a Certified Service Provider for NimbleGen Sequence Capture. (Wed, 03 Feb 2010 13:00:00 GMT)
Finland invests 1.85 million in pan-European infrastructure for biomedical research
( University of Helsinki ) Finland has made its first specific commitment to the development of European biomedical research infrastructures by supporting a joint pilot infrastructure project in bioinformatics, biobanking and translational research. The initial commitment of 1.85 ($2.6) million is to support preparation and pilot studies in 2010. (Wed, 03 Feb 2010 14:40:56 GMT)
Finland Adds $2.6M for European Translational Research Effort
NEW YORK (GenomeWeb News) – Finland has invested €1.9 million ($2.6 million) to support a pan-European pilot project that will involve bioinformatics, biobanking, and translational research efforts in order to ensure that its scientists are involved in developing European biomedical infrastructures, the European Molecular Biology Laboratory (MBL) said today. (Wed, 03 Feb 2010 16:06:01 GMT)
Molecular Devices Returns to Life Sciences Marketplace
SUNNYVALE, Calif., Feb. 3 /PRNewswire/ -- Today, Molecular Devices, Inc.--now part of Danaher Corporation--re-launched the Molecular Devices brand into the life sciences marketplace. (Wed, 03 Feb 2010 16:14:32 GMT)
Talking Genomic Medicine and More
Science Progress is encouraged by the upcoming meeting of the Secretary’s Advisory Committee for Genetics, Health, and Society at the Department of Health and Human Services, saying that this sort of federal-level discussion of the future of genomic medicine is just what is needed. (Wed, 03 Feb 2010 16:20:50 GMT)
This Week in Genome Research
In the early, online edition of Genome Research this week, MD Anderson Cancer Center researcher Jean-Pierre Issa and his team found DNA methylation levels shifts at some genes in aging mouse tissues. (Wed, 03 Feb 2010 16:35:10 GMT)
In ACLU v. Myriad, It's Scientific Accuracy, 0, and Wild Speculation, 1
Unless you've been living under a sequencer, you already know that the ACLU v. Myriad gene patent hearings began yesterday . Daily Scan was there for the circus, held in a standing-room-only courtroom in downtown New York. The ACLU attorneys spent much of their time arguing that isolated DNA was not "markedly different" from native DNA, and therefore not eligible for patent protection. (Wed, 03 Feb 2010 16:35:20 GMT)
Helicos to Install Second Sequencer at Stanford; Sells Instrument to Private Research Institute
Helicos BioSciences said today that it will install a second Helicos Genetic Analysis system at Stanford University, and that it has sold an instrument to a private research institute, a deal originally announced a year ago. (Wed, 03 Feb 2010 17:05:11 GMT)
TGen and Geisinger Health System announce strategic partnership
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Wed, 03 Feb 2010 17:19:22 GMT)
Geisinger and TGen Announce Strategic Partnership to Shape Future of Personalized Medicine
Geisinger Health System and the Translational Genomics Research Institute (TGen) today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Wed, 03 Feb 2010 17:20:56 GMT)
Penn biologists determine microRNA activity is suppressed in mouse ovum
( University of Pennsylvania ) Scientists studying RNA activity, the so-called dark matter of the biological world, may have found the first event in reprogramming a differentiated oocyte into pluripotent blastomeres of the embryo. (Wed, 03 Feb 2010 17:34:38 GMT)
Simbios Molecular Dynamics workshop
On March 1-2, Simbios , the NIH Center for physics-based Simulation of Biological Structures at Stanford University, will be hosting the Molecular Dynamics Workshop Series . The first workshop will cover running and developing MD algorithms on GPUs with OpenMM , a programming library which provides tools for molecular modeling simulation, and PyOpenMM , the Python version of OpenMM. (Wed, 03 Feb 2010 18:35:08 GMT)
Scientists map epigenome of human stem cells during development
( Agency for Science, Technology and Research (A*STAR), Singapore ) Singapore and US scientists have mapped major components of the epigenome and DNA methylation for the entire human DNA sequence, and compared three cell types representing three stages of human development. (Wed, 03 Feb 2010 19:26:20 GMT)
Roche NimbleGen Array Sales Rise 44 Percent in '09
Sales of Roche NimbleGen arrays rose 44 percent in 2009 compared to 2008, fueled by "continued strong performance" of Roche NimbleGen's sequence capture arrays as well as the introduction of its high-throughput MS 200 microarray scanner, according to the firm, the company said this week. (Wed, 03 Feb 2010 20:20:10 GMT)
Livestock Genomics, Breeding Wins $11M from USDA
NEW YORK (GenomeWeb News) –The US Department of Agriculture has awarded nearly $11 million in grants to genomics and genetics studies focused on livestock animal development and breeding. (Wed, 03 Feb 2010 20:50:08 GMT)
Dr. Klaus Lindpaintner Begins Serving as Vice President of R&D and CSO for Strategic Diagnostics
NEWARK, Del.----SDI , a provider of biotechnology-based products and services, today announced that Dr. Klaus Lindpaintner began serving as Vice President of Research & Development and Chief Scientific Officer on February 1, 2010 as previously disclosed in its January 11, 2010 news release. (Wed, 03 Feb 2010 21:02:00 GMT)
Navigenics Nets $18M in Financing Round
NEW YORK (GenomeWeb News) – Navigenics has reeled in $18 million in Series C financing from an investment round that included The Procter and Gamble Company, Kleiner Perkins Caufield and Byers, and Mohr Davidow Ventures. (Wed, 03 Feb 2010 21:05:12 GMT)
Vermillion Closes Settlement Debt with HDC
NEW YORK (GenomeWeb News) – Health Discovery Corp. today said that it has received the final payment owed to it by Vermillion under a patent infringement lawsuit. (Wed, 03 Feb 2010 21:05:21 GMT)
Atlas Biolabs to Offer Roche NimbleGen Target-Enrichment, Sequencing Services
Roche NimbleGen said today that it has certified genomics service provider Atlas Biolabs to provide target-enrichment and sequencing services using its technologies. (Wed, 03 Feb 2010 21:20:08 GMT)
Oxford Nanopore Raises $28 Million to Start Protein Analysis Work, Continue DNA Sequencing Research
Oxford Nanopore Technologies announced this week it has raised £17.4 million ($28 million) which it will use to start work in protein analysis, in addition to "accelerated" development of its core technology for DNA sequencing and continued work in its lead project in DNA sequencing. (Wed, 03 Feb 2010 21:20:18 GMT)
NextGen Developing Biomarker Assays for Takeda
Biomarker firm NextGen Sciences this week announced it has entered into an agreement with Takeda Pharmaceutical to develop validated protein biomarker assays. (Wed, 03 Feb 2010 21:20:28 GMT)
Recent Research Papers of Note
The authors recently introduced a method to facilitate the analysis of phosphopeptides by performing automated online TiO 2 enrichment of phosphopeptides prior to MS analysis. (Wed, 03 Feb 2010 22:05:11 GMT)
University of Pittsburgh Earmarks $350K from NIH Grant for WaferGen Real-Time PCR Studies
Wafergen Biosystems said this week that researchers at the University of Pittsburgh have earmarked $350,000 from an NIH grant to pay for research that will use Wafergen's SmartChip real-time PCR system as part of a larger multi-institution study on the genomics of chronic lung disease. (Wed, 03 Feb 2010 22:20:08 GMT)
Affymetrix's Q4 Sales Surge 13 Percent
NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth-quarter revenues increased 13 percent, driven by a 30 percent increase in sales of its genotyping products. (Wed, 03 Feb 2010 23:35:08 GMT)
TGen Partners with Geisinger on Obesity Research
NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute will partner with Geisinger Health System in Pennsylvania in an effort that will use genomics technologies and clinical data to discover causes of obesity, diabetes, and other metabolic conditions. (Wed, 03 Feb 2010 23:35:29 GMT)
Penn Biologists Determine MicroRNA Activity Is Suppressed in Mouse Ovum
Biologists at the University of Pennsylvania studying oocytes in mice, the immature egg cells necessary for sexual reproduction, have demonstrated an unusual behavior in microRNA, or miRNA, activity that may be the first event in reprogramming the differentiated oocyte into pluripotent blastomeres of the embryo. (Thu, 04 Feb 2010 01:08:57 GMT)
SDSU Provides Web Tool for Plant Breeders
A new Web-based tool at South Dakota State University helps plant breeders & researchers worldwide analyze molecular data to select best grapes & other plant stock to breed better plants. (Thu, 04 Feb 2010 01:40:39 GMT)
TGen, Geisinger Health System sign strategic research agreement
The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Thu, 04 Feb 2010 05:31:47 GMT)
P&G joins existing Navigenics investors in $18M Series C financing
Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round. (Thu, 04 Feb 2010 05:46:57 GMT)
Geisinger Health System and TGen sign research agreement
Geisinger Health System and the Translational Genomics Research Institute (TGen) today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. (Thu, 04 Feb 2010 06:02:58 GMT)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids. (Thu, 04 Feb 2010 07:24:23 GMT)
USPTO issues three patents to Rosetta Genomics
Rosetta Genomics today announced that the United States Patent and Trademark Office (USPTO) has issued three patents to the company covering the composition of matter of human microRNAs. (Thu, 04 Feb 2010 07:31:57 GMT)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids. (Thu, 04 Feb 2010 07:42:00 GMT)
Finland commits 1.85M as initial funding for development of European biomedical research infrastructures
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010. (Thu, 04 Feb 2010 08:32:07 GMT)
The Translational Genomics Research Institute Partners With Cambridge, UK, Firm In Cancer Research
The Translational Genomics Research Institute (TGen) and Horizon Discovery have announced plans to develop human disease models for use in TGen's cancer research. A research-collaboration and sub-licensing agreement will allow TGen investigators to use Horizon's GENESIS™ and X-MAN™ technologies to accelerate the search for new drug targets, biomarkers and anti-cancer agents, which could provide ... (Thu, 04 Feb 2010 11:41:45 GMT)
Geisinger And TGen Announce Strategic Partnership To Shape Future Of Personalized Medicine
Geisinger Health System and the Translational Genomics Research Institute (TGen) announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the possible ... (Thu, 04 Feb 2010 12:41:55 GMT)
Research and Markets: Bioinformatics for Glycobiology and Glycomics: an Introduction
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Bioinformatics for Glycobiology and Glycomics: An Introduction" to their offering. (Thu, 04 Feb 2010 13:54:00 GMT)
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
FDA granted the authorization in a Jan. 21 letter to Lee's Summit, Mo.-based ViraCor. The letter was made available ion the agency's web site this week. (Thu, 04 Feb 2010 16:05:15 GMT)
GeneOhm to Acquire Infectio Diagnostic; Company Will Receive $12M VC Cash Infusion
NEW YORK, Oct. 21 (GenomeWeb News) - Microarray company GeneOhm Sciences will acquire Infectio Diagnostic in a stock swap expected to close in November, the firms said today. (Thu, 04 Feb 2010 16:05:50 GMT)
Darwin's Handwriting Would Make Our Mothers Cry
"Darwin had difficult handwriting ," writes PZ Myers. The Darwin Online collection has digital versions of Charles Darwin's notes and letters. Taking a look at this outline of his species theory, Darwin's handwriting does indeed look spidery and small, with cross-outs and sideways notes. (Thu, 04 Feb 2010 16:06:10 GMT)
What, No Big Names Could Make It?
Bill Gates, Eric Lander, Maynard Olson, Leena Peltonen, and George Church led a panel discussion on personal genomics at the University of Washington on Wednesday night, covering the state of genomics and the effect of studies linking genetic variation to disease. (Thu, 04 Feb 2010 16:06:20 GMT)
What Else is New?, It Should Be Titled
A National Science Foundation report says the US is at risk of losing its status as a leader in science and technological innovation, says a New York Times article . As science and technology flourishes outside the US, domestic science education lags and many Americans remain ignorant of basic science -- or, refuse to accept basic scientific tenets like evolution and the Big Bang. The report ... (Thu, 04 Feb 2010 16:06:30 GMT)
LabCorp Pens Cancer Dx-Development Deal With CancerGuide Diagnostics
According to CancerGuide, its initial tests will be designed to help physicians assess the risk of cancer recurrence and for therapy selection. (Thu, 04 Feb 2010 16:35:08 GMT)
CAREERS: Making It Easy on the Reviewer
At Effect Measure, Revere takes a break from an all-consuming grant application to discuss how to make reading the proposal easy on the reviewer — which hopefully makes your application more successful . "My goal is always to write the grant in such a way that it writes its own review. (Thu, 04 Feb 2010 16:35:18 GMT)
At Close to No Cost
George Whitesides discusses using paper-based devices for medical tests for use in the developing world and in conflict zones. Almutairi"s lab is focused on utilizing and advancing bionanotechnology to detect, treat and prevent diseases mitigating their huge social and economic costs. (Thu, 04 Feb 2010 16:35:28 GMT)
Researcher to track spread of disease, malware and power outages
( Virginia Tech ) An assistant professor with the Virginia Tech College of Engineering has won a Department of Energy Early Career Award to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to ... (Thu, 04 Feb 2010 17:30:40 GMT)
This Week in Nature
In this week's issue of Nature , a UK research team reports that they have identified large, rare chromosomal copy number changes linked to early obesity . In a group of 300 Caucasian individuals with early onset obesity, including 143 with developmental delays, the researchers found recurrent, rare deletions of various sizes affecting a chromosome 16 region called 16p11.2 — previously tied to ... (Thu, 04 Feb 2010 18:20:08 GMT)
Researcher to track spread of disease, malware and power outages
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail. (Thu, 04 Feb 2010 18:22:59 GMT)
Product Watch
EMLab P&K, a TestAmerica company, has launched new analytical services to detect pathogens in food and environmental samples using real-time PCR technology. (Thu, 04 Feb 2010 19:05:13 GMT)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
MANCHESTER, England & NEW YORK----Pfizer Inc. and DxS today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 , an immunotherapy vaccine in development for the treatment of glioblastoma multiforme . (Thu, 04 Feb 2010 21:00:00 GMT)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results
Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2009. Recent financial and operating highlights include the following: (Thu, 04 Feb 2010 21:01:00 GMT)
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2009
SAN DIEGO----Illumina, Inc. today announced its financial results for the fourth quarter and fiscal year of 2009. (Thu, 04 Feb 2010 21:05:00 GMT)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary ... (Thu, 04 Feb 2010 21:10:55 GMT)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results
AUSTIN, Texas, Feb. 4 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the fourth quarter and year ended December 31, 2009. (Fri, 05 Feb 2010 00:04:32 GMT)
New computational tool for cancer treatment
Researchers have developed an approach for creating new IDO inhibitors by computer-assisted structure-based drug design. (Fri, 05 Feb 2010 00:23:58 GMT)
Centre to Tackle Big Issues in 2010 Research gathe
A range of internationally recognised scientists, including Professor Sir Peter Gluckman, will address a range of cutting edge issues in reproductive and genetic science at the second Annual Scientific Research Colloquium held by the Centre for Reproduction and Genomics (CRG) a collaboration between the University of Otago and AgResearch, New Zealand’s leading primary industry research ... (Fri, 05 Feb 2010 00:53:05 GMT)
Finland Commits $2.6M to European Research Infrastructure to Link Bfx, Biobanking, Translational Research
Finland has pledged $2.6 million (€1.85 M) to help develop European biomedical research infrastructure, which will help support a joint pilot infrastructure project in bioinformatics, biobanking, and translational research, the European Molecular Biology Laboratory said said in a statement. (Fri, 05 Feb 2010 04:20:08 GMT)
Holloway competition jumpstarts student businesses
By: Krista Macomber Now in its 22nd year, the Holloway Prize Innovation-to-Market Competition offers graduate and undergraduate students at the University of New Hampshire, Keene State College and Plymouth State University the chance to win up to $10,000 in seed money t... (Fri, 05 Feb 2010 04:21:36 GMT)
Arrayit's VIP DNA testing technology receives patent protection in Israel
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea ... (Fri, 05 Feb 2010 05:31:41 GMT)
TGen finalizes alliance with Van Andel Research Institute
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both nonprofit institutes. (Fri, 05 Feb 2010 07:19:22 GMT)
TGen completes strategic alliance and affiliation agreement with VARI
The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes. (Fri, 05 Feb 2010 08:16:31 GMT)
Virginia Tech professor wins grant to formulate mathematical framework for flu prevention
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail. (Fri, 05 Feb 2010 09:01:42 GMT)
Results validating performance of GSN’s proprietary Parental Support technology published
Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF). (Fri, 05 Feb 2010 09:17:01 GMT)
Press Release
Pfizer Inc. Posted on:05 Feb 10 Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the ... (Fri, 05 Feb 2010 09:20:52 GMT)
Biomedical Research: Finland Invests 1.85 Million Euros In Pan-European Infrastructure
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M euros is to support preparation and pilot studies in 2010. This funding is meant to ensure Finland's ... (Fri, 05 Feb 2010 11:34:08 GMT)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ...
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ... (Fri, 05 Feb 2010 12:30:00 GMT)
TGen And Geisinger Health System Announce Strategic Partnership
The Translational Genomics Research Institute (TGen) and Geisinger Health System have announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the ... (Fri, 05 Feb 2010 12:37:21 GMT)
EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ... (Fri, 05 Feb 2010 13:31:31 GMT)
NTU researchers complete the world's first in-depth study of the malaria parasite genome
( Nanyang Technological University ) Groundbreaking research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria. Assistant Professor Zbynek Bozdech and his team of researchers, including graduate students and post-doctorals from SBS' Division of Genomics & Genetics, have scored a world ... (Fri, 05 Feb 2010 15:27:00 GMT)
SEC, Acacia, CombiMatrix, Korea NIH, Affymetrix, Nanogen, Aushon Biosystems, Oxford Gene Technology, RPCI, BlueGnome
The Securities and Exchange Commission has declared that Acacia Research and CombiMatrix can split apart on Aug. 15 after completing a share trade. At that date, every 10 shares of Acacia Research-CombiMatrix common stock will be redeemed for one share of CombiMatrix Corporation common stock. (Fri, 05 Feb 2010 16:05:09 GMT)
A mossy renaissance
The moss field wasn't getting enough respect, a group of researchers believed, and they decided to do something about it (Fri, 05 Feb 2010 16:27:15 GMT)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ...
VILLA GUARDIA, Italy, Feb. 5 /PRNewswire-FirstCall/ -- Gentium S.p.A. (Fri, 05 Feb 2010 17:13:22 GMT)
Illumina, Facing Dip in Array Demand, Posts 12-Percent Rise in Q4 Sales
"Significant growth" in demand for high-throughput sequencing products drove Illumina's fourth quarter sales up 12 percent year over year, offsetting a decline in array sales, the company said this week. (Fri, 05 Feb 2010 18:20:08 GMT)
1 2 3 4 5 Next
